Treatment of breast cancer cells with a small-molecule inhibitor of BRD4, JQ1, resulted in no immediate activation of the drug-resistant genes, but long-time treatment or destabilization of LSD1 by PELI1 decommissioned the BRD4/LSD1/NuRD complex.
[Proceedings of the National Academy of Sciences of the United States of America]
7992332
AAAAAAAA
items
1
apa
0
default
asc
1
171699
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
